Grant: Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
University of Alberta
$70,000.00
Direct Non-Viral Gene Delivery for Bone Regeneration
EF 2010-11
Résumé
Up to 10-20% of fractures are associated with impaired healing. The current gold standard method is an autologous bone graft, where the patient's own bone tissue is harvested from a second site, such as the iliac crest, and used to repair the defect. Even if the quantity and quality of harvested bone is sufficient, this second surgery presents additional risks. To this end, protein-based treatments were developed using bone morphogenetic protein-2 (BMP-2), a protein expressed during fracture healing. A BMP-2 solution was soaked into absorbable collagen sponges and implanted at the injury site. While successful, the large amount of expensive protein required for a positive outcome has impeded this treatment's widespread use. We chose to deliver the gene for BMP-2 such that the host cells express the protein at the injury site. We have choosen non-viral carriers, based on their superior safety profile compared to viral carriers, to deliver plasmid DNA containing the BMP-2 gene. An 'IRES' DNA sequence allows simultaneous expression of BMP-2 and green fluorescent protein (GFP) to easily detect successful gene delivery. Positively charged polyethylenimine modified with lipids can bind the negatively charged plasmid DNA and condense it into a compact complex that can easily be taken up by the cell. The efficiency of our polymer/plasmid complexes to deliver the BMP-2 gene are first tested in vitro using rat bone marrow stromal cells. Upon finding the optimal gene delivery conditions, complex-loaded scaffolds will be implanted subcutaneously in rats. Success of gene delivery will be evaluated with GFP expression using flow cytometry and microscopy. The ability to induce osteogenic differentiation following BMP-2 gene delivery will be assessed by activity of the osteogenic enzyme alkaline phosphatase and changes in gene expression using real-time PCR. The final test will be tissue mineralization, which will be assessed with histology and micro-computer tomography (u-CT).
Programme
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
229632
Name
Rose Laura
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Musculoskeletal Health and Arthritis
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Direct Non-Viral Gene Delivery for Bone Regeneration
Programtype2
Studentship Programs
Orgnameinp2
University of Alberta
Cihramount2
$70,000
Cihrequipment2
$0
Programname2
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Keyworddelim
Biomaterials; Bone; Bone Regeneration; Gene Delivery; Gene Therapy; Polymers; Tissue Engineering
Abstract
Up to 10-20% of fractures are associated with impaired healing. The current gold standard method is an autologous bone graft, where the patient's own bone tissue is harvested from a second site, such as the iliac crest, and used to repair the defect. Even if the quantity and quality of harvested bone is sufficient, this second surgery presents additional risks. To this end, protein-based treatments were developed using bone morphogenetic protein-2 (BMP-2), a protein expressed during fracture healing. A BMP-2 solution was soaked into absorbable collagen sponges and implanted at the injury site. While successful, the large amount of expensive protein required for a positive outcome has impeded this treatment's widespread use. We chose to deliver the gene for BMP-2 such that the host cells express the protein at the injury site. We have choosen non-viral carriers, based on their superior safety profile compared to viral carriers, to deliver plasmid DNA containing the BMP-2 gene. An 'IRES' DNA sequence allows simultaneous expression of BMP-2 and green fluorescent protein (GFP) to easily detect successful gene delivery. Positively charged polyethylenimine modified with lipids can bind the negatively charged plasmid DNA and condense it into a compact complex that can easily be taken up by the cell. The efficiency of our polymer/plasmid complexes to deliver the BMP-2 gene are first tested in vitro using rat bone marrow stromal cells. Upon finding the optimal gene delivery conditions, complex-loaded scaffolds will be implanted subcutaneously in rats. Success of gene delivery will be evaluated with GFP expression using flow cytometry and microscopy. The ability to induce osteogenic differentiation following BMP-2 gene delivery will be assessed by activity of the osteogenic enzyme alkaline phosphatase and changes in gene expression using real-time PCR. The final test will be tissue mineralization, which will be assessed with histology and micro-computer tomography (u-CT).
Competitiondate
201010
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Rose, Laura
Approvedterm
2 ans 0 mois
Cihrcontribution2
~ $70,000~ $0~